GB0517184D0 - Compounds - Google Patents
CompoundsInfo
- Publication number
- GB0517184D0 GB0517184D0 GBGB0517184.8A GB0517184A GB0517184D0 GB 0517184 D0 GB0517184 D0 GB 0517184D0 GB 0517184 A GB0517184 A GB 0517184A GB 0517184 D0 GB0517184 D0 GB 0517184D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0517184.8A GB0517184D0 (en) | 2005-08-22 | 2005-08-22 | Compounds |
PCT/EP2006/008204 WO2007022937A1 (en) | 2005-08-22 | 2006-08-18 | Pyridazine derivatives with antiinflammatory activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0517184.8A GB0517184D0 (en) | 2005-08-22 | 2005-08-22 | Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0517184D0 true GB0517184D0 (en) | 2005-09-28 |
Family
ID=35098093
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0517184.8A Ceased GB0517184D0 (en) | 2005-08-22 | 2005-08-22 | Compounds |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0517184D0 (en) |
WO (1) | WO2007022937A1 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2155689B1 (en) | 2007-05-31 | 2015-07-08 | Boehringer Ingelheim International GmbH | Ccr2 receptor antagonists and uses thereof |
WO2009140078A1 (en) * | 2008-05-16 | 2009-11-19 | The Procter & Gamble Company | Treatment of lower urinary tract dysfunction with cb2-receptor-selective agonists |
US20120053164A1 (en) | 2008-12-19 | 2012-03-01 | Boehringer Ingelheim International Gmbh | Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd |
US20120129858A1 (en) * | 2009-04-20 | 2012-05-24 | Institute For Oneworld Health | Compounds, compositions and methods comprising pyridazine sulfonamide derivatives |
WO2011073154A1 (en) | 2009-12-17 | 2011-06-23 | Boehringer Ingelheim International Gmbh | New ccr2 receptor antagonists and uses thereof |
EP2569298B1 (en) | 2010-05-12 | 2015-11-25 | Boehringer Ingelheim International GmbH | Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments |
WO2011141477A1 (en) | 2010-05-12 | 2011-11-17 | Boehringer Ingelheim International Gmbh | New ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments |
WO2011144501A1 (en) | 2010-05-17 | 2011-11-24 | Boehringer Ingelheim International Gmbh | Ccr2 antagonists and uses thereof |
JP5636094B2 (en) | 2010-05-25 | 2014-12-03 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | CCR2 receptor antagonist |
US8962656B2 (en) | 2010-06-01 | 2015-02-24 | Boehringer Ingelheim International Gmbh | CCR2 antagonists |
EP2731941B1 (en) | 2011-07-15 | 2019-05-08 | Boehringer Ingelheim International GmbH | Novel and selective ccr2 antagonists |
CN106220572B (en) * | 2011-10-28 | 2019-12-13 | 因西必泰克新有限公司 | Pyridazine derivative compound, application, composition and kit and preparation method |
ES2917979T3 (en) * | 2013-07-31 | 2022-07-12 | Novartis Ag | 1,4-disubstituted pyridazine derivatives and their use to treat conditions related to SMN deficiency |
EP3317270B1 (en) | 2015-07-02 | 2020-05-13 | Centrexion Therapeutics Corporation | (4-((3r,4r)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-yl)(5-methyl-6-(((2r,6s)-6-(p-tolyl)tetrahydro-2h-pyran-2-yl)methylamino)pyrimidin-4yl)methanone citrate |
AR117169A1 (en) | 2018-11-28 | 2021-07-14 | Bayer Ag | (TIO) PYRIDAZINE AMIDES AS FUNGICIDE COMPOUNDS |
WO2020127780A1 (en) | 2018-12-20 | 2020-06-25 | Bayer Aktiengesellschaft | Heterocyclyl pyridazine as fungicidal compounds |
WO2021239766A1 (en) | 2020-05-27 | 2021-12-02 | Bayer Aktiengesellschaft | Active compound combinations |
PE20231307A1 (en) | 2020-06-18 | 2023-08-24 | Bayer Ag | COMBINATIONS OF ACTIVE COMPOUNDS |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2474214A1 (en) * | 2002-02-05 | 2003-08-14 | Novo Nordisk A/S | Novel aryl- and heteroarylpiperazines |
MXPA06001053A (en) * | 2003-07-29 | 2006-04-11 | Novo Nordisk As | Pyridazinyl- piperazines and their use as histamine h3 receptor ligands. |
FR2864080B1 (en) * | 2003-12-23 | 2006-02-03 | Sanofi Synthelabo | 1-PIPERAZINE-AND-1-HOMOPIPERAZINE-CARBOXYLATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE |
-
2005
- 2005-08-22 GB GBGB0517184.8A patent/GB0517184D0/en not_active Ceased
-
2006
- 2006-08-18 WO PCT/EP2006/008204 patent/WO2007022937A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2007022937A1 (en) | 2007-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0508472D0 (en) | Compounds | |
GB0503962D0 (en) | Compounds | |
GB0507602D0 (en) | Compounds | |
GB0502418D0 (en) | Compounds | |
GB0502316D0 (en) | Compounds | |
EP1961741A4 (en) | m-CARBAZOLYLPHENYL COMPOUNDS | |
GB0517184D0 (en) | Compounds | |
GB0508463D0 (en) | Compounds | |
GB0502310D0 (en) | Compounds | |
GB0502299D0 (en) | Compounds | |
GB0503961D0 (en) | Compounds | |
AP2007004220A0 (en) | Motilide compounds | |
GB0505084D0 (en) | Compounds | |
EP1907385A4 (en) | Compounds | |
GB0506467D0 (en) | Compounds | |
GB0505086D0 (en) | Compounds | |
GB0508460D0 (en) | Compounds | |
GB0505509D0 (en) | Compounds | |
GB0505735D0 (en) | Compounds | |
GB0501985D0 (en) | Compounds | |
GB0505085D0 (en) | Compounds | |
GB0501984D0 (en) | Compounds | |
GB0503145D0 (en) | Compounds | |
GB0502544D0 (en) | Compounds | |
GB0507041D0 (en) | Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |